ISONIAZID PREVENTIVE THERAPY FOR TUBERCULOSIS - ARE WE LOSING OUR ENTHUSIASM

被引:20
作者
MEHTA, JB
DUTT, AK
HARVILL, L
HENRY, W
机构
[1] ALVIN C YORK VET ADM MED CTR, MURFREESBORO, TN USA
[2] TENNESSEE DEPT HLTH & ENVIRONM, DIV TB CONTROL, NASHVILLE, TN USA
[3] E TENNESSEE STATE UNIV, QUILLEN DISHNER COLL MED, DEPT INTERNAL MED, JOHNSON CITY, TN 37614 USA
[4] E TENNESSEE STATE UNIV, QUILLEN DISHNER COLL MED, MED EDUC SECT, JOHNSON CITY, TN 37614 USA
[5] MEHARRY MED COLL, DEPT MED, NASHVILLE, TN 37208 USA
关键词
D O I
10.1378/chest.94.1.138
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Contact investigation activities of the Tennessee Department of Health and Environment (TDHE) Tuberculosis (TB) Control Program from 1979 to 1985 were reviewed. Out of 32,722 identified contacts, 6,030 (20.1 percent) were infected (positive purified protein derivative [PPD]). Only 2,731 (45 percent) of the infected contacts were started on preventive therapy. Both the absolute number and the relative percentage of infected contacts starting on INH prevention therapy have gradually declined over the years. While 569 (67 percent) of the infected contacts were started on preventive treatment in 1979, only 296 (37.5 percent) received isoniazid (INH) preventive therapy in 1985. Although an increasing percentage of those starting preventive therapy completed the prescribed course, the enthusiasm for recommending preventive therapy has declined for the infected individuals above the age of 15. More enthusiasm and efforts are needed from physicians in initiating and maintaining INH preventive therapy to accomplish tuberculosis eradication.
引用
收藏
页码:138 / 141
页数:4
相关论文
共 15 条
[1]  
[Anonymous], B WHO
[2]   PREVENTION OF TUBERCULOSIS AMONG TUBERCULIN REACTORS - MAXIMIZING BENEFITS, MINIMIZING RISKS [J].
COMSTOCK, GW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (19) :2729-2730
[3]  
DUTT AK, 1987, AM REV RESPIR DIS, V135, P138
[4]  
FARER LS, 1986, AM REV RESPIR DIS, V134, P402
[5]  
GEISELER PJ, 1987, AM REV RESPIR DIS, V135, P3
[6]  
ISEMAN MD, 1985, AM REV RESPIR DIS, V132, P735
[7]  
KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991
[8]  
MILLER B, 1987, AM REV RESPIR DIS, V135, P1
[9]  
NOLAN CM, 1986, AM REV RESPIR DIS, V133, P431
[10]   THE AGE THRESHOLD FOR ISONIAZID CHEMOPROPHYLAXIS - A DECISION-ANALYSIS FOR LOW-RISK TUBERCULIN REACTORS [J].
ROSE, DN ;
SCHECHTER, CB ;
SILVER, AL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (19) :2709-2713